LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,502 | 6,866 | 7,272 | 8,071 | 3,627 |
| TOTAL | $6,504 | $6,933 | $7,435 | $8,221 | $3,708 |
| Non-Current Assets | |||||
| Intangibles | 243 | 0 | 0 | 0 | 0 |
| TOTAL | $243 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $6,747 | $6,933 | $7,435 | $8,221 | $3,708 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 27 | 39 | 22 | 87 | 84 |
| Accrued Expenses | 501 | 263 | 320 | 437 | 949 |
| Other current liabilities | 12,059 | 6,102 | 7,807 | 8,103 | N/A |
| TOTAL | $12,587 | $6,404 | $8,149 | $8,627 | $1,033 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $12,587 | $6,404 | $8,149 | $8,627 | $1,033 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2 | 94,710 | 94,710 | 94,696 | 65,723 |
| Common Shares | N/A | N/A | 9 | 947 | 657 |
| Retained earnings | -434,590 | -428,081 | -429,414 | -429,192 | -426,088 |
| Other shareholders' equity | 5,573 | 47 | 92 | 29 | 0 |
| TOTAL | $-5,840 | $529 | $-714 | $-406 | $2,675 |
| Total Liabilities And Equity | $6,747 | $6,933 | $7,435 | $8,221 | $3,708 |